Semaglutide
- All
- News
- Videos
- Web Stories
-
Weight-Loss Drugs Set To Get Cheaper In India As Semaglutide Patents Expire
The cost of popular weight-loss injections like Ozempic and Wegovy is expected to fall in India as patents on semaglutide expire in March 2026, paving the way for generic versions and wider access to anti-obesity medications.
-
Ozempic Revolution In India? Semaglutide Patent Expiry Sparks Generic Rush: Report
As the patent for semaglutide, the active ingredient in Ozempic, nears expiry, Indian pharmaceutical companies are preparing to launch cheaper generic versions.
-
Tanmay Bhat Admits To Using Weight Loss Drugs: Why It Isn't Working For Him
GLP-1 drugs are highly effective, FDA-approved medications for managing type 2 diabetes
-
Ozempic Teeth? Dentist Warns Of New Side Effect Linked To Tooth Decay And Cavities
Ozempic is the brand name for a GLP 1 receptor agonist prescribed for type 2 diabetes.
-
Novo Nordisk Sues Telehealth Company Over 'Knock-Off' Weight Loss Drugs, Flags Patient Safety Risks
The lawsuit, filed in the US, alleges that Hims infringed Novo Nordisk's patent by mass marketing compounded semaglutide products that have not been cleared by the US Food and Drug Administration (FDA).
-
Obesity Expert Debunks Myths Around "Natural" WeightLoss Remedies
"Weight loss with berberine is mild. Two to four kilos over a few months, not 10-15% body weight loss," said the expert
-
Ozempic May Lower Risk Of Epilepsy In Diabetes Patients, New Study Finds
The study offers early evidence of neurological benefits from these diabetes and weight loss medications.
-
Ozempic Enters India: Diabetes Drug, Not A Miracle Fix, Novo Nordisk MD To NDTV
In an exclusive interaction with NDTV, Managing Director of Novo Nordisk India, Vikrant Shrotriya, said the launch of injectable semaglutide marks a significant moment for diabetes treatment.
-
Ozempic Too Costly? 7 Cheaper And Clinically Approved Alternatives Available In India
Ozempic has hit the Indian market and will be available at Rs 2,200 per week. But did you know that there are alternatives which can also aid in weight loss?
-
Can Non-Diabetics Take Ozempic For Weight Loss? Doctor Answers
Ozempic is the brand name for a medication called semaglutide, which is primarily used to manage type 2 diabetes. It belongs to a class of drugs known as GLP-1 receptor agonists
-
Weight-Loss Drugs Set To Get Cheaper In India As Semaglutide Patents Expire
The cost of popular weight-loss injections like Ozempic and Wegovy is expected to fall in India as patents on semaglutide expire in March 2026, paving the way for generic versions and wider access to anti-obesity medications.
-
Ozempic Revolution In India? Semaglutide Patent Expiry Sparks Generic Rush: Report
As the patent for semaglutide, the active ingredient in Ozempic, nears expiry, Indian pharmaceutical companies are preparing to launch cheaper generic versions.
-
Tanmay Bhat Admits To Using Weight Loss Drugs: Why It Isn't Working For Him
GLP-1 drugs are highly effective, FDA-approved medications for managing type 2 diabetes
-
Ozempic Teeth? Dentist Warns Of New Side Effect Linked To Tooth Decay And Cavities
Ozempic is the brand name for a GLP 1 receptor agonist prescribed for type 2 diabetes.
-
Novo Nordisk Sues Telehealth Company Over 'Knock-Off' Weight Loss Drugs, Flags Patient Safety Risks
The lawsuit, filed in the US, alleges that Hims infringed Novo Nordisk's patent by mass marketing compounded semaglutide products that have not been cleared by the US Food and Drug Administration (FDA).
-
Obesity Expert Debunks Myths Around "Natural" WeightLoss Remedies
"Weight loss with berberine is mild. Two to four kilos over a few months, not 10-15% body weight loss," said the expert
-
Ozempic May Lower Risk Of Epilepsy In Diabetes Patients, New Study Finds
The study offers early evidence of neurological benefits from these diabetes and weight loss medications.
-
Ozempic Enters India: Diabetes Drug, Not A Miracle Fix, Novo Nordisk MD To NDTV
In an exclusive interaction with NDTV, Managing Director of Novo Nordisk India, Vikrant Shrotriya, said the launch of injectable semaglutide marks a significant moment for diabetes treatment.
-
Ozempic Too Costly? 7 Cheaper And Clinically Approved Alternatives Available In India
Ozempic has hit the Indian market and will be available at Rs 2,200 per week. But did you know that there are alternatives which can also aid in weight loss?
-
Can Non-Diabetics Take Ozempic For Weight Loss? Doctor Answers
Ozempic is the brand name for a medication called semaglutide, which is primarily used to manage type 2 diabetes. It belongs to a class of drugs known as GLP-1 receptor agonists
